cancer

3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
Oasmia Rises on New Cancer Combination Drug
Bloomberg
Tue, 05/28/13 - 08:31 am
Oasmia
cancer
A Game-Changing Cancer Screen For Exact Sciences
Seeking Alpha
Tue, 05/21/13 - 12:09 pm
EXACT Sciences
cancer
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha
Mon, 05/20/13 - 05:26 pm
Bristol-Myers Squibb
Merck
nivolumab
lambrolizumab
Roche
PD-L1
melanoma
cancer
lung cancer
3 Small Cap Cancer Stocks With Upcoming Catalysts
Seeking Alpha
Mon, 05/20/13 - 11:58 am
OncoSec Medical
cancer
Cellceutix
Kevetrin
solid tumors
OMS-I110
OMS-I120
OMS-I100
Synta Pharmaceuticals
Puma Biotech Gains After Rival Drug Data Show No Threat
Bloomberg
Sat, 05/18/13 - 11:43 am
Puma Biotechnology
neratinib
breast cancer
cancer
Human Immune-Boosting Cancer Drugs Seen Extending Lives
Bloomberg
Mon, 05/13/13 - 09:11 am
cancer
Merck
Bristol-Myers Squibb
Roche
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
Seeking Alpha
Fri, 05/10/13 - 08:31 am
Cellceutix
AstraZeneca
GSK
Celgene
Eli Lilly
Roche
Pfizer
Pharmacyclics
Kevetrin
cancer
Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs
Fierce Biotech
Thu, 04/18/13 - 07:01 pm
Epizyme
IPOs
R&D
cancer
[video]Some Cancers ‘Absolutely’ Curable: Celgene CEO
CNBC
Fri, 04/12/13 - 09:57 am
Celgene
cancer
Pharma CEOs
J&J releases more Doxil to the market
Fierce Pharma
Tue, 04/9/13 - 02:49 pm
JNJ
Doxil
cancer
chemotherapy
Janssen
Ziopharm moves higher on data from preclinical study of cancer drug Ad-RTS-mIL-12
Yahoo/AP
Tue, 04/9/13 - 02:48 pm
Ziopharm
cancer
Ad-RTS-mIL-12
Bristol-Myers New R&D Chief Plans to Keep Focus on Cancer
Bloomberg
Mon, 04/8/13 - 11:24 am
R&D
cancer
Bristol-Myers Squibb
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
immuno-oncology
cancer
Bristol-Myers Squibb
AbbVie
Ariad Pharmaceuticals
JNJ
Eli Lilly
Novartis
Pfizer
Medivation
Erbitux
Yervoy
Sprycel
Orencia
NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
Yahoo
Thu, 04/4/13 - 09:35 am
NewLink Genetics
NLG919
IDO pathway inhibitors
cancer
3 Contenders With Novel, Non-Invasive Treatments For Cancer
Seeking Alpha
Tue, 04/2/13 - 10:26 am
AngioDynamics
cancer
OncoSec
Agenus
QS-21
NeoPulse
ImmunoPulse
Where Is Exelixis In The Cancer Therapeutics Market?
Seeking Alpha
Mon, 04/1/13 - 11:01 am
Exelixis
cabozantinib
Cometriq
cancer
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/1/13 - 10:58 am
ARQ092
Daiichi Sankyo
Arqule
akt protein inhibitor
cancer
Understanding Why Cancer Vaccines Fail
Motley Fool
Mon, 04/1/13 - 10:46 am
cancer
vaccines
Dendreon
Provenge
Bristol-Myers Squibb
Yervoy
Sanofi
TheraCys
3 Companies Developing Novel Cancer Drug Delivery Platforms
Seeking Alpha
Mon, 03/18/13 - 11:10 am
drug delivery
cancer
Celgene
AngioDynamics
OncoSec

Pages